Home » Newsletters » BioWorld Science

BioWorld Science

July 29, 2010

View Archived Issues

Fumagillin reduces body weight and regulates fat metabolism in vivo

Sinopharm and Merck & Co. to collaborate on HPV vaccine in China

Ciclopiroxolamine vaginal suppositories approved in China

Scientists identify Siglec-8 gene SNP associated with susceptibility to asthma

Rare CNVs in DLGAP2, SYNGAP1 and SHANK2 loci linked to ASDs

MF-766 exhibits high potency in rat model of arthritis

DRL-17822 displays safety and potent activity in preclinical and clinical settings

Allos reports topline data from phase IIb Folotyn trial in NSCLC

Advanced Life Sciences seeks FDA fast track status for Restanza in CABP

UBC and Advanced Life Sciences join to develop antimicrobial peptides

Kyowa Hakko Kirin begins phase II ARQ-197 trial in gastric cancer

ICAgen and Pfizer claim new voltage-gated sodium channel blockers

New taxane prodrugs disclosed by Indian scientists

New mGlu4 modulators identified by Addex Pharmaceuticals

Novel antiviral agents described by Chinese researchers

Bayer Schering Pharma claims new sGC activators

Phase I biosimilar EPO trial begins in patients with renal dysfunction and anemia

Advaxis updates phase I data on ADXS11-001 in cervical cancer

Generex Oral-lyn advances in phase III trial in diabetes type 1

FDA approves Cuvposa for chronic drooling in children with neurological disorders

Phase III trial of Qvar nasal aerosol in seasonal allergic rhinitis meets primary endpoint

FDA approves two new dose strengths of niacin/simvastatin

FDA committee recommends approval of antiplatelet ticagrelor for ACS

Angiotech's MultiStem cell therapy shows promise in phase I trial in AMI

VaxGen and diaDexus merge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Laigo raises €11.5M seed money for targeted protein degradation
BioWorld Science
Laigo Bio BV has raised €11.5 million (US$13.7 million) in a seed round for the further development of a new approach to inducing targeted protein degradation by...